Akebia Therapeutics Inc. buy Leerink Partnrs
Start price
30.04.25
/
50%
€2.11
Target price
30.04.26
-
Performance (%)
-43.36%
Price
16.04.26
€1.25
Summary
This prediction is currently active. Massive losses of -43.36% have been the result for the BUY prediction by Leerink_Partnrs. This prediction currently runs until 30.04.26. The prediction end date can be changed by Leerink_Partnrs at any time. Leerink_Partnrs has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m |
|---|---|---|
| Akebia Therapeutics Inc. | 4.504% | 4.504% |
| iShares Core DAX® | 3.593% | 3.931% |
| iShares Nasdaq 100 | 5.810% | 5.518% |
| iShares Nikkei 225® | 4.075% | 8.460% |
| iShares S&P 500 | 4.142% | 4.039% |
Comments by Leerink_Partnrs for this prediction
In the thread Akebia Therapeutics Inc. diskutieren
Akebia Therapeutics, Inc. (NASDAQ: AKBA) was upgraded by analysts at Leerink Partnrs to a "strong-buy" rating.
Ratings data for AKBA provided by MarketBeat